Cerebral Artery Syndrome Treatment Market size is anticipated to cross USD 5 Billion by the end of 2036, growing at a CAGR of 6% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of cerebral artery syndrome treatment was over USD 2 Billion. The rising incidences of cerebral artery syndrome are a major driver for the growth of the market. Cerebral artery syndrome is a major health problem that affects millions of people worldwide, and it is a leading cause of disability globally. As the population ages and risk factors such as hypertension, diabetes, and smoking become more prevalent, the number of people affected by cerebral artery syndrome is on the rise. For instance, an estimated 1.28 billion persons globally between the ages of 30 and 79 suffer from hypertension, with the majority (two thirds) residing in low- and middle-income nations. This increased prevalence creates a higher demand for effective treatment options.
Furthermore, the rising number of stroke patients is driving the demand for effective stroke treatment options, including medications, medical devices, and rehabilitation therapies. Pharmaceutical companies are investing in developing new stroke treatments, which is also driving the market's growth. In addition, rehabilitation centers are expanding their services to meet the needs of stroke patients, offering a range of therapies to help patients recover and regain their independence.
Growth Drivers
Challenges
Base Year |
2023 |
Forecast Year |
2024-2036 |
CAGR |
~ 6% |
Base Year Market Size (2023) |
~ USD 2 Billion |
Forecast Year Market Size (2036) |
~ USD 5 Billion |
Regional Scope |
|
Surgery Type (Carotid Endarterectomy, Angioplasty, Bypass Surgery)
Cerebral artery syndrome treatment market for the carotid endarterectomy segment is anticipated to hold the largest share of 43% during the forecast period. As it lowers the risk of stroke, carotid endarterectomy is a surgical technique that is becoming more and more common. Therefore, the increasing number of cases of stroke is propelling the growth of the segment. The high success rate of this method is the primary cause of the tremendous growth. Additionally, this sort of surgery is widely accessible, which promotes the growth of this market. The procedure's increased demand has also been attributed to improvements in safety and effectiveness brought about by medical technological breakthroughs.
Distribution Channel (Hospital, Specialty Clinic, Online Pharmacies)
The hospital segment in the cerebral artery syndrome treatment market is expected to hold a share of 50% during the foreseen period. The growth can be attributed to the growing number of patients globally. Also, the presence of a large number of hospitals providing advanced healthcare services. Hospitals have higher acceptance amongst the public, which is estimated to boost market growth. Additionally, hospitals often have dedicated stroke units and rehabilitation services, which are crucial for managing and recovering from cerebral artery syndrome.
Our in-depth analysis of the global market includes the following segments:
Treatment |
|
Surgery Type |
|
Distribution Channel |
|
North American Market Forecast
Cerebral artery syndrome treatment market in North America is expected to hold the largest share of 35% during the projected period. The growth can be attributed to the growing awareness among individuals regarding minimally invasive stroke treatment in the region. Also, the growing prevalence of atrial fibrillation is also driving the market growth in the region. As per a report, in the US, there are annually more than 454,000 hospital admissions with AFib as the major diagnosis. Each year, the illness is a contributing factor in over 158,000 deaths.
APAC Market Statistics
Asia Pacific region in cerebral artery syndrome treatment market is anticipated to hold the second-largest share of 26% during the projected period. The market is growing in the region due to the increasing initiatives taken by the government in the region to spread awareness about the condition. Also, growing investment for the betterment of healthcare infrastructure is propelling the market growth. As per a report, the region invested around USD 10.8 billion from 2008 to 2021 in the healthcare industry. Furthermore, growing R&D activities for the advent of new and advanced treatments are also accelerating the market growth of cerebral artery syndrome treatment in the region.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?